参考文献/References:
[1]Lanning RK,Zai CC,Müller DJ.Pharmacogenetics of tardive dyskinesia:an updated review of the literature[J].Pharmacogenomics,2016,17(12):1339-1351. [2]Caligiuri MP,Teulings HL,Dean CE,et al.A Quantitative Measure of Handwriting Dysfluency for Assessing Tardive Dyskinesia[J].Journal of Clinical Psychopharmacology,2015,35(2):168-174. [3]王宁,谭云龙,杨甫德,等.精神分裂症伴发迟发性运动障碍的血清S100B蛋白浓度研究[J].中国神经精神疾病杂志,2011,37(9):550-553. [4]王坚.中枢神经系统运动障碍的诊断和处理[J].神经病学与神经康复学杂志,2010,7(3):187-189. [5]Peralta V,Campos MS,De Jalón EG,et al.Motor behavior abnormalities in drug-naive patients with schizophrenia spectrum disorders[J].Schizophrenia Research,2010,117(2-3):187-188. [6]Aquino CC,Lang AE.Tardive dyskinesia syndromes:current concepts [J].Parkinsonism&Related Disorders,2014,20(Suppl 1):S113-S117. [7]Rana AQ,Chaudry ZM,Blanchet PJ.New and emerging treatments for symptomatic tardive dyskinesia[J].Drug Design Development&Therapy,2013,7(default):1329-1340. [8]杨志明,高烨,熊文,等.迟发性运动障碍关联因素的研究综述[J].中国实用医药,2009,4(36):236-238. [9]Andreassen OA,Finsen B,Ostergaard K,et al.The relationship between oral dyskinesias produced by long-term haloperidol treatment, the density of striatal preproenkephalin messenger RNA and enkephalin peptide,and the number of striatal neurons expressing preproenkephalin messenger RNA in rats[J].Neuroscience,1999,88(1):27-35. [10]王崴,亢万虎.迟发性运动障碍的相关问题回顾[J].中国健康心理学杂志,2004,12(4):318-320. [11]Tsai G,Goff DC,Chang RW,et al.Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia[J].Am J Psychiatry,1998,155(9):1207-1213. [12]Mehanna R,Jankovic J.Movement disorders in cerebrovascular disease[J].Lancet Neurology,2013,12(6):597. [13]Ellingrod VL,Schultz SK,Arndt S.Association between cytochrome P4502D6(CYP2D6)genotype,antipsychotic exposure, and abnormal involuntary movement scale(AIMS)score[J].Psychiatr Genet,2000,10(1):9-11. [14]Lam LC,Garcia-Barcelo MM,Ungvari GS,et al.Cytochrome P450 2D6 genotyping and association with tardive dyskinesia in Chinese schizophrenic patients [J].Pharmacopsychiatry,2001,34(6):238. [15]Eiselt R,Domanski TL,Zibat A,et al.Identification and functional characterization of eight CYP3A4 protein variants [J].Pharmacogenetics,2001,11(5):447. [16]Li H,Tan Y,Wang Z,et al.Association study on tardive dyskinesia and polymorphisms in COMT and MAOA in Chinese population[J].Psychiatric Genetics,2013,23(4):176. [17]Dean B,Pavey G,Thomas D,et al.Cortical serotonin 7,1D and 1F receptors:Effects of schizophrenia,suicide and antipsychotic drug treatment[J].Schizophrenia Research,2006,88(1):265-274. [18]Inada T,Koga M,Ishiguro H,et al.Pathway-based association analysis of genome-wide screening data suggest that genes associated with the gamma-aminobutyric acid receptor signaling pathway are involved in neuroleptic-induced,treatment-resistant tardive dyskinesia[J].Pharmacogenetics&Genomics,2008,18(4):317. [19]Bird A.Perceptions of epigenetics[J].Nature,2007,447(7143):396-398. [20]Csoka AB,Szyf M.Epigenetic side-effects of common pharmaceuticals:A potential new field in medicine and pharmacology[J].Medical Hypotheses,2009,73(5):770. [21]Furuta Y,Kobayashi I.Mobility of DNA sequence recognition domains in DNA methyltransferases suggests epigenetics-driven adaptive evolution[J].Mobile Genetic Elements,2012,2(6):292-296. [22]Olson CO,Zachariah RM,Ezeonwuka CD,et al.Brain Region-Specific Expression of MeCP2 Isoforms Correlates with DNA Methylation within Mecp2 Regulatory Elements[J].Plos One,2014,9(3):e90645. [23]张苹,李艳丽,安会梅,等.精神分裂症伴迟发性运动障碍患者基因甲基化谱的初步构建[J].中华精神科杂志,2018,51(1): [24]Marcucci G,Yan P,Maharry K,et al.Epigenetics meets genetics in acute myeloid leukemia:clinical impact of a novel seven-gene score [J].Journal of Clinical Oncology,2015,32(6):548-556. [25]Sandoval J,Heyn H,Moran S,et al.Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome[J].Epigenetics,2016,6(6):692-702. [26]冯磊光,曹鸿雁,祁萍萍,等.精神分裂症患者外周血液中Reelin蛋白的表达[J].国际检验医学杂志,2014(10):1291-1292. [27]BNsch D,Wunschel M,Lenz B,et al.Methylation matters Decreased methylation status of genomic DNA in the blood of schizophrenic twins [J].Psychiatry Research,2012,198(3):533-537. [28]Mill J,Tang T,Kaminsky Z,et al.Epigenomic profiling reveals DNA-methylation changes associated with major psychosis[J].American Journal of Human Genetics,2008,82(3):696-711. [29]Petronis A,Gottesman II,Kan P,et al.Monozygotic Twins Exhibit Numerous Epigenetic Differences:Clues to Twin Discordance[J].Schizophrenia Bulletin,2003,29(1):169-178. [30]Ruzicka WB,Subburaju S,Benes FM.Circuit- and Diagnosis-Specific DNA Methylation Changes at γ-Aminobutyric Acid-Related Genes in Postmortem Human Hippocampus in Schizophrenia and Bipolar Disorder[J].Jama Psychiatry,2015,72(6):541. [31]Boyadjieva N,Varadinova M.Epigenetics of psychoactive drugs[J].Journal of Pharmacy&Pharmacology,2012,64(10):1349-1358.
相似文献/References:
[1]邹超杰,程宇琪.肠道微生物在精神分裂症中的研究进展[J].医学信息,2018,31(02):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
ZOU Chao-jie,CHENG Yu-qi.Progress in the Study of Intestinal Microorganism in Schizophrenia[J].Medical Information,2018,31(20):29.[doi:10.3969/j.issn.1006-1959.2018.02.011]
[2]张 健,江 芮.生活技能训练对精神分裂症缓解期患者日常生活能力的影响[J].医学信息,2018,31(03):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
ZHANG Jian,JIANG Rui.Effect of Life Skills Training on Daily Living Ability of Patients with Schizophrenia in Remission Staged[J].Medical Information,2018,31(20):118.[doi:10.3969/j.issn.1006-1959.2018.03.040]
[3]沈雪梅.齐拉西酮与奥氮平治疗首发精神分裂症
疗效及糖脂代谢的影响观察[J].医学信息,2018,31(06):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
SHEN XUE-mei.The Effect of Ziprasidone and Olanzapine in the Treatment of First Episode Schizophrenia and the Effect of Glycolipid Metabolism[J].Medical Information,2018,31(20):130.[doi:10.3969/j.issn.1006-1959.2018.06.044]
[4]张益勋,胡逸萍,钟穗航,等.DNA甲基化在病理性瘢痕中的作用研究[J].医学信息,2018,31(09):46.[doi:10.3969/j.issn.1006-1959.2018.09.015]
ZHANG Yi-xun,HU Yi-ping,ZHONG Sui-hang,et al.Study on the Role of DNA Methylation in Pathological Scars[J].Medical Information,2018,31(20):46.[doi:10.3969/j.issn.1006-1959.2018.09.015]
[5]陈功琦,梁道博.利培酮联合舍曲林治疗精神分裂症阴性症状
疗效和安全性的Meta分析[J].医学信息,2018,31(10):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
CHEN Gong-qi,LIANG Dao-bo.Meta Analysis of Efficacy and Safety of Risperidone Combined with Sertraline in the Treatment of Schizophrenia with Negative Symptoms[J].Medical Information,2018,31(20):65.[doi:10.3969/j.issn.1006-1959.2018.10.020]
[6]孙来顺.氨磺必利与利培酮对精神分裂症患者内分泌及糖脂代谢的影响[J].医学信息,2022,35(10):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
SUN Lai-shun.Effects of Amisulpride and Risperidone on Endocrine And Glucose and Lipid Metabolism in Patients with Schizophrenia[J].Medical Information,2022,35(20):137.[doi:10.3969/j.issn.1006-1959.2022.10.033]
[7]孙占娟.精神分裂症患者的认知康复治疗进展[J].医学信息,2018,31(13):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
SUN Zhan-juan.Progress in Cognitive Rehabilitation Therapy of Schizophrenia Patients[J].Medical Information,2018,31(20):52.[doi:10.3969/j.issn.1006-1959.2018.13.015]
[8]吴金丽.阿立哌唑的临床应用[J].医学信息,2018,31(14):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
WU Jin-li.Clinical Application of Aripiprazole[J].Medical Information,2018,31(20):42.[doi:10.3969/j.issn.1006-1959.2018.14.014]
[9]宋典雄.激励理论指导下的护理干预对精神分裂症患者的影响[J].医学信息,2018,31(18):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
SONG Dian-xiong.The Effect of Nursing Intervention under the Guidance of Motivation Theory on Patients with Schizophrenia[J].Medical Information,2018,31(20):166.[doi:10.3969/j.issn.1006-1959.2018.18.054]
[10]凌 梅,刘静芳.精神分裂症患者研究伙伴的相关研究进展[J].医学信息,2018,31(19):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]
LING Mei,LIU Jing-fang.Progress in Research on Research Partners in Patients with Schizophrenia[J].Medical Information,2018,31(20):48.[doi:10.3969/j.issn.1006-1959.2018.19.016]